Literature DB >> 10747947

Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk.

R K Ganju1, S A Brubaker, R D Chernock, S Avraham, J E Groopman.   

Abstract

The beta-chemokine receptor CCR5 has been shown to modulate cell migration, proliferation, and immune functions and to serve as a co-receptor for the human immunodeficiency virus. We and others have shown that CCR5 activates related adhesion focal tyrosine kinase (RAFTK)/Pyk2/CAK-beta. In this study, we further characterize the signaling molecules activated by CCR5 upon binding to its cognate ligand, macrophage inflammatory protein-1beta (MIP1beta). We observed enhanced tyrosine phosphorylation of the phosphatases SHP1 and SHP2 upon MIP1beta stimulation of CCR5 L1.2 transfectants and T-cells derived from peripheral blood mononuclear cells. Furthermore, we observed that SHP1 associated with RAFTK. However, using a dominant-negative phosphatase-binding mutant of RAFTK (RAFTK(m906)), we found that RAFTK does not mediate SHP1 or SHP2 phosphorylation. SHP1 and SHP2 also associated with the adaptor protein Grb2 and the Src-related kinase Syk. Pretreatment of CCR5 L1.2 transfectants or T-cells with the phosphatase inhibitor orthovanadate markedly abolished MIP1beta-induced chemotaxis. Syk was also activated upon MIP1beta stimulation of CCR5 L1.2 transfectants or T-cells and associated with RAFTK. Overexpression of a dominant-negative Src-binding mutant of RAFTK (RAFTK(m402)) significantly attenuated Syk activation, whereas overexpression of wild-type RAFTK enhanced Syk activity, indicating that RAFTK acts upstream of CCR5-mediated Syk activation. Taken together, these results suggest that MIP1beta stimulation mediated by CCR5 induces the formation of a signaling complex consisting of RAFTK, Syk, SHP1, and Grb2.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747947     DOI: 10.1074/jbc.M000689200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  Chemokines and glial cells: a complex network in the central nervous system.

Authors:  Elena Ambrosini; Francesca Aloisi
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

Review 2.  Focal adhesion kinase-related protein tyrosine kinase Pyk2 in T-cell activation and function.

Authors:  Hanne L Ostergaard; Tara L Lysechko
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  The Src kinase Lyn is required for CCR5 signaling in response to MIP-1beta and R5 HIV-1 gp120 in human macrophages.

Authors:  Brian Tomkowicz; Chuhee Lee; Vipa Ravyn; Ricky Cheung; Andrzej Ptasznik; Ronald G Collman
Journal:  Blood       Date:  2006-04-18       Impact factor: 22.113

Review 4.  B cell receptor signaling in chronic lymphocytic leukemia.

Authors:  Jan A Burger; Nicholas Chiorazzi
Journal:  Trends Immunol       Date:  2013-08-05       Impact factor: 16.687

5.  Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages.

Authors:  Ricky Cheung; Vipa Ravyn; Lingshu Wang; Andrzej Ptasznik; Ronald G Collman
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

6.  Syk regulates multiple signaling pathways leading to CX3CL1 chemotaxis in macrophages.

Authors:  Haein Park; Dianne Cox
Journal:  J Biol Chem       Date:  2011-03-09       Impact factor: 5.157

7.  Reactive oxygen species play a critical role in collagen-induced platelet activation via SHP-2 oxidation.

Authors:  Ji Yong Jang; Ji Hyun Min; Yun Hee Chae; Jin Young Baek; Su Bin Wang; Su Jin Park; Goo Taeg Oh; Sang-Hak Lee; Ye-Shih Ho; Tong-Shin Chang
Journal:  Antioxid Redox Signal       Date:  2014-01-30       Impact factor: 8.401

8.  An arrestin-dependent multi-kinase signaling complex mediates MIP-1beta/CCL4 signaling and chemotaxis of primary human macrophages.

Authors:  Ricky Cheung; Mobeen Malik; Vipa Ravyn; Brian Tomkowicz; Andrzej Ptasznik; Ronald G Collman
Journal:  J Leukoc Biol       Date:  2009-07-20       Impact factor: 4.962

9.  B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.

Authors:  Maite P Quiroga; Kumudha Balakrishnan; Antonina V Kurtova; Mariela Sivina; Michael J Keating; William G Wierda; Varsha Gandhi; Jan A Burger
Journal:  Blood       Date:  2009-06-02       Impact factor: 22.113

10.  Functional activation of proline-rich tyrosine kinase2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Authors:  Meiying Wang; Hongsheng Sun; Wei Zhang; Yuanchao Zhang
Journal:  BMC Musculoskelet Disord       Date:  2009-11-17       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.